Artiva Biotherapeutics, Inc. (ARTV) Stock Research

Artiva Biotherapeutics, Inc.

· ARTV

Dashboard

Financials

Ratios

Valuation

Statistics

337.905 M

-1.69%

Today

Artiva updates safety, translational data for AlloNK with rituximab

ARTV

7:44 AM

Over a week ago

Artiva Biotherapeutics provides update on AlloNK data disclosures

ARTV

Sep 8, 7:45 AM

Artiva Biotherapeutics files $400M mixed securities shelf

ARTV

Aug 6, 5:27 PM

Artiva Biotherapeutics reports Q2 EPS (63c), consensus (64c)

ARTV

Aug 6, 5:08 PM

Fourteen new option listings and one option delisting on July 22nd

Jul 22, 8:30 AM

Artiva Biotherapeutics highlights AlloNK data presented at EULAR 2026

ARTV

Jun 8, 6:38 AM

Artiva Biotherapeutics price target raised by $23 at Needham, here's why

ARTV

May 12, 10:06 AM

Artiva Biotherapeutics price target raised by $17 at Wedbush, here's why

ARTV

May 11, 7:47 AM

Artiva Biotherapeutics price target raised by $20 at H.C. Wainwright, here's why

ARTV

May 8, 11:39 AM

Artiva reports data from clinical trials evaluating AlloNK

ARTV

May 8, 6:37 AM

Artiva Biotherapeutics reports Q1 EPS (95c), consensus (84c)

ARTV

May 8, 6:34 AM

Artiva Biotherapeutics appoints Huston as Chief Financial Officer

ARTV

Feb 24, 8:16 AM

Artiva Biotherapeutics appoints Sorg to board of directors

ARTV

Feb 19, 8:12 AM

Artiva Biotherapeutics announces safety, translational data from AlloNK

ARTV

Nov 12, 7:31 AM

Artiva Biotherapeutics reports Q3 EPS (88c) vs (92c) last year

ARTV

Nov 12, 7:04 AM

Morning Movers: Regional banks in focus after reporting Q3 results

+10

Oct 17, 8:48 AM

Artiva Biotherapeutics price target raised by $5 at Wedbush, here's why

ARTV

Oct 17, 7:59 AM

No more stories

Charts